All cancer types
Open
Phase 1/2
This study is looking at a drug called T3P-Y058-739 (T3P) for solid cancers.
A solid cancer is any cancer apart from a blood cancer such as leukaemia, lymphoma and myeloma.
Recruitment start: 2 June 2022
Recruitment end: 31 August 2027
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Kevin Harrington
T3 Pharmaceuticals AG
IQVA BIOTECH
Last reviewed: 27 Feb 2026
CRUK internal database number: 18049
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
